Americord Launches Cord Blood Topic Center

NEW YORK–(BUSINESS WIRE)–#Americord–Americord, the fastest growing cord blood bank in the country, and a
leader in the advancement of umbilical cord blood, cord tissue, and
placenta tissue banking, announces the launch of its Cord Blood Topic

Recognizing that expectant parents and new mothers have questions about
stem cells, their potentially life-saving benefits, and ways to preserve
them for future use, Americord has created a library of articles on a
range of relevant topics. From pregnancy tips and birth planning to stem
cell science and clinical trials, the content is focused on healthy
pregnancies and growing families.

“We are excited to launch our new Topic Center to provide the resources
expectant parents need to make informed decisions about stem cells and
cord blood banking,” commented Erin Willigan, Vice President of
Marketing for Americord. “We are committed to providing our current and
future clients with informative content that offers insights, expertise,
and unbiased advice during their pregnancy and beyond.”

The Cord Blood Topic Center is now live at

About Americord Registry

Americord Registry is a leader in the advancement of umbilical cord
blood, cord tissue and placenta tissue banking. Americord collects,
processes, and stores newborn stem cells from umbilical cord blood for
future medical or therapeutic use, including the treatment of more than
80 blood diseases such as sickle cell anemia and leukemia. Founded in
2008, Americord is registered with the FDA and operates in all 50
states. The company’s laboratory is CLIA Certified and complies with all
federal and state guidelines and applicable licenses. Americord is
headquartered in New York, NY. You may visit Americord Registry’s
website at
for more information.


Alysha Bullock, 866­503­6005